RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia
Year: 2017
Type: conference-abstract
Source: European Respiratory Journal
Authors: Steven Nathan, Juergen Behr, Harold R Collard, Vincent Cottin, Marius M Hoeper, Fernando Martinez, Tamera Corte, Anne Keogh, Hanno Leuchte, Nesrin Mogulkoc, Silvia Ulrich, Wim Wuyts, Stephen Malcolm, Sukrut Shah, Mia Yao, Athol Wells
Institutions: Inova Health System, Ludwig-Maximilians-Universität München, University of California, San Francisco, Hospices Civils de Lyon, Hôpital Louis Pradel, Medizinische Hochschule Hannover, NewYork–Presbyterian Hospital, Weill Cornell Medical Center, The University of Sydney, Royal Prince Alfred Hospital, St Vincent's Hospital Sydney, Ege Üniversitesi Tıp Fakültesi Hastanesi, University Hospital Zurich, KU Leuven, Bayer (Germany), Merck & Co., Inc., Rahway, NJ, USA (United States), Bayer (China), Royal Brompton Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2780271417